| Literature DB >> 18671883 |
Abstract
BACKGROUND: The current challenge of Systems Biology is to integrate high throughput data sets for simulating the complexity of biological networks, exploit the evolution of nature-designed networks that maintain the robustness of a biological system, and thereby generate novel, experimentally testable hypotheses. In order to simulate non-linear biological complexities, we have previously developed an Enzyme-Centric mechanistic modeling approach and validated it using metabolic network in E. coli. The idea is to use prior knowledge of catalytic and regulatory mechanisms of each enzyme within the metabolic network to build a dynamic model for investigating the network level regulation and thus understand the nature design principle behind the network.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18671883 PMCID: PMC3146071 DOI: 10.1186/1752-0509-2-70
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
Figure 1Simulation of Metabolic Flux from Aspartate to the Branched Chain Amino Acid (BCAA) Biosynthetic Pathways in . A. The metabolic network from glucose, through TCA cycle, to amino acids. The mathematical model of colored pathways was simulated here. Each color represents an operon that regulates the same color enzyme levels in the network. B. The abbreviations of enzymes: TDA, threonine deaminase; AHAS, acetohydroxy acid synthase; IR, acetohydroxy acid isomeroreductase; DAD, dihydroxy acid dehydrase; TB, transaminase B; TC, transaminase C; IPMS, α-isopropylmalate synthase; IPMI, α-isopropylmalate isomerase; IPMDH, β-isopropylmalate dehydrogenase; LIV-I, leucine, isoleucine, and valine transporter I; LS, leucine specific transporter, AKI, aspartate kinase I; AKIII, aspartate kinase III; HDHI, homoserine dehydrogenase I; ASD, semialdehyde dehydrogenase; HSK, homoserine kinase; TS, threonine synthase. The abbreviations of metabolites: Thr, threonine; Ile, isoleucine; Val, valine; Leu, leucine; Glu, glutamate; Ala, alanine; Pyr, pyruvate; αKB, α-ketobutyrate; αAL, α-acetolactate; αAHB, α-aceto-hydroxybutyrate; αDHIV, α,β-dihydroxy-isovalerate; αDMV, α, β-dihydroxy-β-methylvalerate; αKIV, α-ketoisovalerate; αKMV, α-keto-β-methylvalerate; αKG, α-ketoglutarate; αIPM, α-isopropylmalate; βIPM, β-isopropylmalate; αKIC, α-ketoisocaproate; ex-Ile, extracellular isoleucine; ex-Val, extracellular valine; ex-Leu, extracellular leucine, Asp, aspartate; AspP, Aspartyl phosphate; ASA, aspartate semialdehyde; Hse, homoserine; HseP, homoserine phosphate. kMech models used for each enzyme are italicized. Allo: allosteric, Sim: simple, PBiBi: Ping Pong Bi Bi enzyme mechanisms. Enzyme reactions are indicated by arrows. Feedback inhibition patterns are indicated by dashed lines. Activation is indicated by a plus sign, and inhibitions are indicated by vertical bars.
Figure 2Interaction of Feedback Loops. Simple Feedback Loops: Simulation of threonine (Thr) biosynthetic pathway starting from aspartate with three feedback inhibition loops. Interaction of Feedback Loops: Threonine biosynthetic pathway connected with the downstream BCAA pathways. The graphical insets show the approach (minutes) to steady state (μM) synthesis and utilization of the substrates, intermediates, and end-products of the pathways. Where available, the ranges of reported values for pathway intermediate and end-product levels in cells growing in a glucose minimal salts medium are shown in parentheses (μM) in the inset graphs. Dashed lines indicate feedback regulation. Plus sign is positive feedback and minus sign is negative feedback.
Figure 3Network Level Regulation. A. The linear conversion model of the metabolic network. B. The corresponding non-linear, enzymecentric model. The grey arrow starting from Pyr depicts metabolic flow shifting to valine while pyruvate (Pyr) increasing. Black vertical arrows depict up- or down- regulated metabolites. C and D are the spectra of threonine (upstream of Pyr) and isoleucine (downstream of Pyr) responses over the Pyr perturbation using Model A and Model B, respectively. X-axis: Pyr from 50 to 10,000 uM. Y-axis: the simulated steady state levels of threoine and isoleucine at given Pyr concentrations. The dish images are growth assays given low (left) and high (right) Pyr. E. The spectrum of valine production using the Model B. F. The black arrow on the top right-hand corner depicts while Pyr passing the threshold, turning on the reverse TC enzyme reaction to switch the direction of metabolic flux.
Figure 4Simulation of the Branched Chain Amino Acid (BCAA) Biosynthetic Pathways in A. Simulation of treatments in wild type (ilvA+) LT2; B. Simulation of treatments in the TDA_Ile feedback resistant mutant (ilvA 219); αKB is an inhibitor for glucose transporter. Low αKB (Y-axis) indicates growth; high αKB indicates growth suppression. Solid line: Sulfometuron Methyl (SM) + valine (Val); Dotted line: SM + Val + Ile (isoleucine); Dashed line: control with no treatment.
Figure 5The Interactome Model of RNA Transcription and Spliceosome. A. The protein factory model of RNA Polymerase II and spliceosome. B. The T7 polymerase model without interacting with spliceosome. C. to E. Simulations of the in vitro RNA splicing assay. Black squares: measured premRNA; Solid lines: simulated pre-mRNA curves; Black triangles: measured mature mRNA; Dotted lines: simulated mRNA curves. Black bars: standard deviations of data. The interactome of Pol II and spliceosome (NEs) increases the affinity of NEs to the pre-mRNA (smaller Km) as demonstrated by perturbing Km (NEs to pre-mRNA). The value is 50 nM in C and 1 nM in D while Km (RNase to pre-mRNA) is 50 nM in both cases. D. The pre-mRNA protected by PolII interactome is in steady state to maintain mature mRNA production. E. The viral T7 polymerase simulation. Mature mRNA is rapid degraded without protection. Km (NEs to pre-mRNA) = Km (RNase to pre-mRNA) = 50 nM.
Figure 6Comparison of Current Modeling Approaches Using the Simple Enzyme Model.